20th International Symposium on Atherosclerosis (ISA 2024)

20th International Symposium on Atherosclerosis (ISA 2024) is organized by International Atherosclerosis Society (IAS), MCI Global and will be held from Dec 04 - 06, 2024 at Oman Convention & Exhibition Centre, Muscat, Muscat, Oman.

Description:
Following the theme “Towards Prevention of Cardiometabolic Diseases through Precision Medicine,” congress attendees can expect to gain a better understanding of how precision medicine can be used in the prevention, detection, and management of cardiometabolic diseases, including atherosclerosis. ISA 2024 will provide a platform for researchers, clinicians, and healthcare professionals to share knowledge, discuss challenges, and explore opportunities in an inclusive and engaging setting.

The Scientific Committee, comprised of global leaders, is committed to developing a diverse program of cutting-edge science that is inclusive of presentations from both international experts renowned for their research and contributions to cardiometabolic medicine as well as young scientists who are just starting to make their mark in the field. The congress will also highlight the perspectives of patients, caregivers, and other healthcare stakeholders.

In addition to the scientific program, the congress will encourage collaboration, support networking, and host exhibitors who will showcase the newest technological and pharmaceutical innovations. And while in Oman, you must explore all the country has to offer from the World Heritage Sites to the date farms and wadis.

Active participants will leave with wonderful memories as well as new strategies for how they can improve health outcomes and reduce the global burden of cardiometabolic diseases.

Main Topics

• Cardiometabolic Risk Management & Prediction
• Lipids
• Lipoproteins Disorders
• Inflammation & Thrombosis
• Diabetes
• Obesity
• Hypertension
• Metabolic Syndrome
• Chronic Kidney Disease
• Metabolic Liver Disease
• Environmental Health & Pollution
• Health Economics
• Health Ethics & Equity
• Personalized Medicine, Genomics, and Omics
• Digital Health Technologies & Artificial Intelligence
• Imaging
• Patient and Citizens Involvement
• Social Media: Role & Use

Topics of Parallel Sessions

• Advances in familial hypercholesterolemia
• Applying artificial intelligence and omics technologies in atherosclerotic cardiovascular disease
• Challenges and opportunities in cardiometabolic diseases in a social context: Role of social media, ethics, patient communities and educational programs
• Diabetes and atherosclerosis: Prevention, management, and personalized care
• Dyslipidemia and cardiovascular disease in pediatric age group
• Dyslipidemia in microvascular complications in diabetic patients
• Emerging new therapies and gene therapies in atherosclerotic cardiovascular diseases
• Emerging role of environment and pollution in cardiovascular disease
• Emerging science in cardiovascular disease and role of inflammation, stress, and thrombosis
• Health economics and policy considerations related to cardiometabolic diseases
• Latest clinical trial design, in-process, outcome
• Lipoprotein(a), HDL and apoB in atherosclerosis: Pathophysiology, diagnosis, and treatment
• Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): Epidemiology, pathogenesis, and treatment
• Novel biomarkers and new emerging technology in atherosclerotic disease
• Novel therapies for obesity and cardiometabolic diseases
• Obesity and cardiometabolic diseases: Role of adipose tissue, inflammation, and gut microbiota
• Precision medicine in atherosclerotic disease: Challenges and opportunities
• Recent advances in imaging in atherosclerotic cardiovascular disease
• Registries on lipid disorders and screening programs
• Renocardiac syndrome: Pathophysiology, diagnosis, prevention, and treatment
• Role of lifestyle intervention, behavior, and nutraceuticals in management of chronic comorbidities related to heart disease
• Triglyceride-rich lipoproteins and cardiovascular disease: Implications for prevention and treatment
• Women’s cardiovascular health issues